Letters

Human Subjects I read with interest the Ex Libris article "Doing Research on People" (November 16, 1987, p. 23) by Ruth Macklin. I was very disappointed by the tone and approach she took. Perhaps some of this suffered from the space limitations in which she was forced to work, and I hope to one day read the book. However, the article is all that many people may get to see. Since she has a very important and visible role in a major medical college, herr attitudes undoubtedly will influence oth

Written byMarvin E. Jaffe
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I read with interest the Ex Libris article "Doing Research on People" (November 16, 1987, p. 23) by Ruth Macklin. I was very disappointed by the tone and approach she took. Perhaps some of this suffered from the space limitations in which she was forced to work, and I hope to one day read the book. However, the article is all that many people may get to see. Since she has a very important and visible role in a major medical college, herr attitudes undoubtedly will influence others. Thus, I think that the ambiguity and imprecision in the piece should be resolved.

should not have to resort to the circumlocu tion of"hav(ing) an interest in the success of the research." Most research is not succes ful in coming to an unambiguous answer Requiring a personal interest in success as a condition for participation would greatly re strict research. Altruism, curiosity ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies